Fertility Blog

Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as PCOS, isn’t a one-size-fits-all condition, and your care shouldn’t be either. Whether you're hoping to regulate your cycle, manage symptoms, or grow your family, finding a specialist who listens, educates, and creates a plan around your goals can make all the difference.

At a glance → A coalition of 56 patient and professional organizations announced on May 12, 2026 that polycystic ovary syndrome will now be called polyendocrine metabolic ovarian syndrome, abbreviated PMOS → The decision followed a 14-year consensus process led by researchers at Monash University, with input from more than 22,000 patients and health professionals across six continents → Adoption will be gradual, with both names appearing in medical records, lab reports, and patient materials until PMOS becomes the standard term → Diagnostic criteria and treatment protocols are not affected by the renaming; fertility care for PMOS uses the same clinical approach as PCOS care In this article, you will find a plain-language breakdown of the PCOS name change, why your diagnosis and care will stay the same, and what the shift could mean for fertility treatment and research, from a reproductive endocrinologist who specializes in the condition.

Last updated February 2026 The world of fertility can be overwhelming to navigate, and this holds especially true for many women of color. Harmful stereotypes, a lack of representation, and injustices in the healthcare system can cause women of color, especially Black women, to feel isolated from the conversation and discouraged from seeking fertility support.

IVF success rates are highest with younger eggs and generally decline as egg age increases, especially after 40. However, ovarian response, sperm health, embryo quality, diagnosis, and treatment history also matter. National averages show broad trends, but only a fertility specialist can estimate your individual chances based on your testing, history, and goals.

GLP-1 medications like Wegovy, Mounjaro, and Ozempic can all be used to treat type 2 diabetes, but they also show promise in treating symptoms of polycystic ovary syndrome (PCOS). Here's what you need to know.

Rebecca* is a wife, a mother, and a practicing Orthodox Jew. She is also among the 11 percent of women in the United States who have experienced infertility.